S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.03%) $0.927
USD/NOK
(0.19%) $10.86
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.31%) $92.29

Realtime updates for Virpax Pharmaceuticals, [VRPX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

16.75% $ 4.26

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders...

Stats
Today's Volume 15 399.00
Average Volume 24 151.00
Market Cap 4.99M
EPS $0 ( 2024-03-27 )
Next earnings date ( $0 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.360
ATR14 $0.0760 (1.78%)
Insider Trading
Date Person Action Amount type
2024-01-29 Singh Vanila Buy 25 000 Stock Option (right to buy)
2024-01-29 Shah Vinay Buy 112 000 Stock Option (right to buy)
2024-01-29 Jambulingam Thani Buy 25 000 Stock Option (right to buy)
2024-01-29 Mathias Sheila Buy 112 000 Stock Option (right to buy)
2024-01-29 Dubin Michael F Buy 25 000 Stock Option (right to buy)
INSIDER POWER
75.23
Last 71 transactions
Buy: 2 396 200 | Sell: 387 701

Virpax Pharmaceuticals, Correlation

10 Most Positive Correlations
XBIO0.884
TRIP0.875
LTRPA0.868
SCWX0.852
SVAC0.851
GOODM0.845
MIND0.832
YTEN0.832
PRPO0.829
NVFY0.824
10 Most Negative Correlations
LWAC-0.895
SRAC-0.874
AFINO-0.852
NETE-0.845
RAVN-0.839
AMRB-0.82
LMRKN-0.82

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Virpax Pharmaceuticals, Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-12.97
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.510
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.270
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.120

Financial Reports:

No articles found.

Virpax Pharmaceuticals,

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators